XML 187 R23.htm IDEA: XBRL DOCUMENT v3.25.0.1
STATEMENTS OF CONSOLIDATED CASH FLOWS - CERC - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities:      
Net Income $ 1,019 $ 917 $ 1,057
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 1,439 1,401 1,288
Deferred income taxes 221 31 20
Gain on divestitures 0 (13) 303
Changes in other assets and liabilities:      
Accounts receivable and unbilled revenues, net 84 (423) 461
Inventory (42) (167) 259
Taxes receivable 27 74 19
Accounts payable 210 (302) 203
Current regulatory assets and liabilities 86 (1,152) (67)
Non-current regulatory assets and liabilities 644 109 (167)
Other operating activities, net 14 60 79
Net cash provided by operating activities 2,139 3,877 1,810
Cash Flows from Investing Activities:      
Capital expenditures 4,513 4,401 4,419
Proceeds from divestitures 0 144 2,075
Other investing activities, net (24) (24) (14)
Net cash provided by (used in) investing activities (4,489) (4,233) (1,628)
Cash Flows from Financing Activities:      
Increase (decrease) in short-term borrowings, net (4) (10) 452
Payments of commercial paper, net (539) (1,055) (74)
Proceeds from long-term debt and term loans, net 3,955 6,044 2,089
Payments of long-term debt and term loans 1,050 3,190 1,795
Payment of debt issuance costs (35) (55) (36)
Other financing activities, net (28) (25) (7)
Net cash provided by (used in) financing activities 2,271 374 (345)
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash (79) 18 (163)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 109 91 254
Cash, Cash Equivalents and Restricted Cash at End of Period 30 109 91
CERC      
Cash Flows from Operating Activities:      
Net Income 540 512 725
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 522 493 448
Deferred income taxes 55 (41) 178
Gain on divestitures 0 0 557
Changes in other assets and liabilities:      
Accounts receivable and unbilled revenues, net 73 (410) 376
Accounts receivable/payable–affiliated companies (38) 81 (41)
Inventory (6) (101) 50
Taxes receivable (55) 89 0
Accounts payable 43 (250) 190
Current regulatory assets and liabilities 85 (1,098) (112)
Non-current regulatory assets and liabilities 31 (54) (132)
Other current assets and liabilities 24 85 13
Other non-current assets and liabilities (2) (1) (2)
Other operating activities, net (24) 21 2
Net cash provided by operating activities 1,068 2,312 856
Cash Flows from Investing Activities:      
Capital expenditures 1,439 1,619 1,661
Decrease (increase) in notes receivable–affiliated companies (1) 1 0
Proceeds from divestitures 0 0 2,075
Other investing activities, net (19) 23 8
Net cash provided by (used in) investing activities (1,419) (1,643) 406
Cash Flows from Financing Activities:      
Increase (decrease) in short-term borrowings, net (4) (10) 452
Payments of commercial paper, net (115) 321 94
Proceeds from long-term debt and term loans, net 399 2,006 927
Payments of long-term debt and term loans 0 2,332 475
Increase in notes payable-affiliated companies 0 0 (1,517)
Payment of debt issuance costs (3) (14) (14)
Contribution from parent 290 500 289
Payments of Dividends 442 496 844
Other financing activities, net (3) (1) (1)
Net cash provided by (used in) financing activities 352 (668) (1,277)
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash 1 1 (15)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 1 0 15
Cash, Cash Equivalents and Restricted Cash at End of Period $ 2 $ 1 $ 0